Ardsley Advisory Partners’s Gilead Sciences GILD Stock Holding History

Ardsley Advisory Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,000	Closed	-$297K	–	149
2016 Q3	$316K	Hold	4,000	–	–	0.05%	111
2016 Q2	$333K	Sell	4,000 -500	-11%	-$44.4K	0.06%	101
2016 Q1	$413K	Buy	4,500 +2,000	+80%	+$180K	0.06%	84
2015 Q4	$253K	Sell	2,500 -6,000	-71%	-$624K	0.03%	118
2015 Q3	$835K	Sell	8,500 -175,000	-95%	-$19.4M	0.2%	65
2015 Q2	$21.7M	Buy	183,500 +5,000	+3%	+$546K	2.72%	9
2015 Q1	$17.5M	Sell	178,500 -65,500	-27%	-$6.65M	2.44%	7
2014 Q4	$23M	Sell	244,000 -436,900	-64%	-$45.2M	3.65%	6
2014 Q3	$72.5M	Buy	680,900 +10,900	+2%	+$1.07M	9.55%	2
2014 Q2	$55.5M	Buy	670,000 +538,000	+408%	+$41.9M	7.08%	1
2014 Q1	$9.35M	Buy	132,000 +19,500	+17%	+$1.53M	1.4%	22
2013 Q4	$8.45M	Buy	+112,500	New	+$7.83M	1.12%	25
2013 Q3	–	Sell	-8,500	Closed	-$436K	–	160
2013 Q2	$436K	Buy	+8,500	New	+$443K	0.1%	84

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ardsley Advisory Partners's GILD Position: Q4 2016 in Review

Ardsley Advisory Partners sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 4,000 shares — an estimated $297K sold.

Ardsley Advisory Partners first reported a position in GILD in Q2 2013 and held it in 13 quarters. The position peaked at $72.5M in Q3 2014. 1,573 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

Ardsley Advisory Partners reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
Ardsley Advisory Partners sold 4,000 Gilead Sciences shares in Q4 2016, an estimated $297K.
Ardsley Advisory Partners first reported a position in Gilead Sciences in Q2 2013 and held it in 13 quarters.
Ardsley Advisory Partners's Gilead Sciences position peaked at $72.5M in Q3 2014.
1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Ardsley Advisory Partners's 13F filing for Q4 2016, filed 14 Feb 2017.